IDH2 and glioma: To do this, we reviewed all glial tumours archived at our institution from 2009–2018, corresponding with our institution’s adaptation of IDH mutation testing after the initial discovery in 2008,13 and identified four patients with conflicting IDH mutation status longitudinally.